在大鼠前列腺照射模型及血小板生成素模拟物试点研究中阐明血管与神经损伤对勃起功能障碍的相对影响
该试点研究在大鼠前列腺放疗模型中单次给药血小板生成素模拟物(TPOm;RWJ-800088),以区分血管与神经损伤在放射性勃起功能障碍(RI-ED)中的作用。结果显示TPOm可保护血管结构与功能,但未改善海绵体神经损伤,也未在9周时预防RI-ED。作者认为单纯血管保护不足以预防RI-ED,海绵体神经损伤起关键作用。
要点
- TPOm可防止放疗所致阴茎动脉横截面积改变(P = .036)。
- TPOm未改善海绵体神经损伤的神经元损伤标志物基因表达。
- TPOm未在9周时预防RI-ED,提示血管保护单独不足。
核心结论
- 数据提示单纯血管保护不足以预防放射性勃起功能障碍,海绵体神经损伤起关键作用。
- 需要进一步研究以阐明RI-ED的多因素性质,并确定调整给药方案后的TPOm能否通过直接或血管保护效应减轻神经损伤。
研究设计与样本
- 试点研究采用大鼠前列腺放疗模型,单次分割适形前列腺放疗后10分钟单次给予血小板生成素模拟物(TPOm;RWJ-800088)。
- 放疗后9周评估勃起功能和动脉功能,用逆转录聚合酶链反应定量神经标志物,并用免疫荧光显微镜进一步表征放疗和TPOm的血管效应。
主要发现
- 假手术组和接受放疗加TPOm的动物对全身给予肼屈嗪表现出显著动脉血管舒张(增加24.1% ± 7.3%;配对t检验P = .03)。
- 接受放疗加溶媒的动物未能产生血管舒张反应(增加-7.4% ± 9.9%;配对t检验P = .44)。
- TPOm防止了放疗所致阴茎动脉横截面积改变(P = .036),但未改善海绵体神经损伤(以神经元损伤标志物基因表达评估)。
- 尽管有显著的结构和功能血管保护效应及神经损伤/恢复标志物的一些差异趋势,TPOm未在9周时预防RI-ED(以海绵体神经刺激后海绵体内压监测评估)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出需要进一步研究以阐明RI-ED的多因素性质,并确定调整给药方案后的TPOm能否减轻神经损伤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Radiation therapy (RT) offers an important and curative approach to treating prostate cancer, but it is associated with a high incidence of erectile dysfunction (ED). It is not clear whether the etiology of radiation-induced ED (RI-ED) is driven by RT-mediated injury to the vasculature, the nerves, or both. This pilot study sought to distinguish the effects of vascular and nerve injury in RI-ED by applying a vascular radioprotectant in a rat model of prostate RT. METHODS: A single dose of the thrombopoietin mimetic (TPOm; RWJ-800088), previously shown to mitigate radiation-induced vascular injury, was administered 10 minutes after single-fraction conformal prostate RT. Nine weeks after RT, rats were assessed for erectile and arterial function. Nerve markers were quantified with reverse transcriptase polymerase chain reaction. Immunofluorescent microscopy further characterized vascular effects of RT and TPOm. RESULTS: Sham animals and animals that received RT and TPOm showed significant arterial vasodilation in response to systemic hydralazine (24.1% ± 7.3% increase; P = .03 in paired t test). However, animals that received RT and vehicle were unable to mount a vasodilatory response (-7.4% ± 9.9% increase; P = .44 in paired t test). TPOm prevented RT-induced change in the penile artery cross-sectional area (P = .036), but it did not ameliorate cavernous nerve injury as evaluated by gene expression of neuronal injury markers. Despite significant structural and functional vascular protective effects and some trends for differences in nerve injury/recovery markers, TPOm did not prevent RI-ED at 9 weeks, as assessed by intracavernous pressure monitoring after cavernous nerve stimulation. CONCLUSIONS: These data suggest that vascular protection alone is not sufficient to prevent RI-ED and that cavernous nerve injury plays a key role in RI-ED. Further research is required to delineate the multifactorial nature of RI-ED and to determine if TPOm with modified dosing regimens can mitigate against nerve injury either through direct or vascular protective effects.
引用
- Ashcraft KA, Hannan JL, Eichenbaum G, et al. Clarifying the Relative Impacts of Vascular and Nerve Injury That Culminate in Erectile Dysfunction in a Pilot Study Using a Rat Model of Prostate Irradiation and a Thrombopoietin Mimetic. Int J Radiat Oncol Biol Phys. 2018. PMID: 30529374. doi:10.1016/j.ijrobp.2018.11.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。